Neurogene, Inc. (NGNE)
21.23
-0.03
(-0.14%)
USD |
NASDAQ |
Dec 12, 13:15
Neurogene Market Cap: 328.85M for Dec. 12, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 924.98M |
| Verastem, Inc. | 719.30M |
| Anavex Life Sciences Corp. | 339.52M |
| Coherus Oncology, Inc. | 165.59M |
| Ocugen, Inc. | 429.44M |
Market Cap Related Metrics
| Price to Book Value | 1.238 |
| Price | 21.23 |
| Earnings Yield | -20.86% |